Navigation Links
Premier Wen Visits Asymchem's Tianjin Facility
Date:11/10/2011

TIANJIN, China, Nov. 10, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd., a leading research-based contract manufacturer of intermediates, API's and Drug Products for the pharmaceutical industry with sites in the U.S. and China, was pleased to receive a visit from Premier Wen Jiabao at its GMP R&D and manufacturing facility on the afternoon of October 24th, 2011. Premier Wen, a member of the Standing Committee of the Political Bureau of the CPC Central Committee and Premier of the State Council, visited Asymchem during his investigative trip to observe the development of Tianjin Binhai New Area where Asymchem is based. Premier Wen was accompanied by Mr. Zhang Gaoli, the Tianjin Municipal Committee Secretary.

During his visit, Premier Wen praised the CEO of Asymchem, Dr. Hao Hong, for Asymchem's growth. Asymchem has risen from a company with $250,000 USD in registered capital to one with $65 million USD in manufacturing output. Dr. Hong states, "Premier Wen spoke highly of Asymchem's innovation and its presence as a leading Chinese pharmaceutical company, which has the power to attract international talents."

Premier Wen also visited the Analysis and Testing Center and the process R&D center at Asymchem, commenting positively on Asymchem's dual focus on internationally advanced facilities and the involvement of high-tech talents. Dr. Hong adds, "Through the pursuance of high-tech innovation, Asymchem will continue to contribute to the development of the biopharmaceutical and strategically important new industries in the Tianjin Binhai New Area and throughout the whole of China."

With a diverse range of capabilities ranging from the synthesis of sophisticated organic chemicals in the lab to commercial scale production of API's, Asymchem offers a comprehensive list of services for pharmaceutical customers. For more information on Asymchem, please visit our website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Life Science (Tianjin) Co. Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin Becomes Premier Founding Sponsor of RMECs New Osteobiologics Registry
2. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
3. Mathematics and Biochemistry Research Earn Top Prize at Nations Premier High School Science Competition
4. Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29
5. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
6. Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners
7. Mexico Premiere for Money-Saving Pharma Leak Testing Equipment
8. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
9. Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
10. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
11. Premier Research Achieves Double-Digit Growth in Functional Sourcing for the Third Straight Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Research Triangle Park, NC (PRWEB) , ... March ... ... drug development company engaged in the development of a new orally administered treatment ... Company’s Advisory Board. , CEO John Didsbury states, “As we seek to uniquely ...
(Date:3/27/2017)... 2017 Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular ... detection of foodborne pathogens,  today announced that Mary Duseau ... 2017 Convention on March 29 at 9:50am ET. The conference ... About Roka Bioscience ... Roka Bioscience is a molecular ...
(Date:3/27/2017)... March 27, 2017 Cousins Properties (NYSE: ... leading biotechnology companies, has signed a 10-year, approximately 125,000 square-foot ... office asset located in the Westshore submarket of ... that Amgen has chosen Corporate Center for their new location ... , president and chief executive officer of Cousins Properties. "Amgen ...
(Date:3/27/2017)... MOSCOW , March 27, 2017 Infectex Ltd., a Russian ... Phase 2b-3 clinical study of SQ109 added to the standard drug therapy regimen in ... by scientists at Sequella, Inc. ( USA ) and the US National ... ... Maxwell Biotech Venture Fund Logo ...
Breaking Biology Technology:
(Date:3/2/2017)... -- Summary This report provides all the information ... and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):